» Articles » PMID: 22688341

Adipose Tissue MicroRNAs As Regulators of CCL2 Production in Human Obesity

Abstract

In obesity, white adipose tissue (WAT) inflammation is linked to insulin resistance. Increased adipocyte chemokine (C-C motif) ligand 2 (CCL2) secretion may initiate adipose inflammation by attracting the migration of inflammatory cells into the tissue. Using an unbiased approach, we identified adipose microRNAs (miRNAs) that are dysregulated in human obesity and assessed their possible role in controlling CCL2 production. In subcutaneous WAT obtained from 56 subjects, 11 miRNAs were present in all subjects and downregulated in obesity. Of these, 10 affected adipocyte CCL2 secretion in vitro and for 2 miRNAs (miR-126 and miR-193b), regulatory circuits were defined. While miR-126 bound directly to the 3'-untranslated region of CCL2 mRNA, miR-193b regulated CCL2 production indirectly through a network of transcription factors, many of which have been identified in other inflammatory conditions. In addition, overexpression of miR-193b and miR-126 in a human monocyte/macrophage cell line attenuated CCL2 production. The levels of the two miRNAs in subcutaneous WAT were significantly associated with CCL2 secretion (miR-193b) and expression of integrin, α-X, an inflammatory macrophage marker (miR-193b and miR-126). Taken together, our data suggest that miRNAs may be important regulators of adipose inflammation through their effects on CCL2 release from human adipocytes and macrophages.

Citing Articles

Transcriptional dynamics in type 2 diabetes progression is linked with circadian, thermogenic, and cellular stress in human adipose tissue.

Rivera-Alvarez I, Vazquez-Lizarraga R, Mendoza-Viveros L, Sotelo-Rivera I, Viveros-Ruiz T, Morales-Maza J Commun Biol. 2025; 8(1):398.

PMID: 40057615 PMC: 11890630. DOI: 10.1038/s42003-025-07709-5.


A Missing Puzzle in Preclinical Studies-Are CCR2, CCR5, and Their Ligands' Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?-Evidence from Rodent Models and Clinical Studies.

Bober A, Mika J, Piotrowska A Int J Mol Sci. 2024; 25(20).

PMID: 39457105 PMC: 11508617. DOI: 10.3390/ijms252011323.


Metabolomic Alteration in Adipose Monocyte Chemotactic Protein-1 Deficient Mice Fed a High-Fat Diet.

Yan L, Rust B, Sundaram S, Nielsen F Nutr Metab Insights. 2024; 17:11786388241280859.

PMID: 39372559 PMC: 11452861. DOI: 10.1177/11786388241280859.


The Role of Chemokines in Obesity and Exercise-Induced Weight Loss.

He W, Wang H, Yang G, Zhu L, Liu X Biomolecules. 2024; 14(9).

PMID: 39334887 PMC: 11430256. DOI: 10.3390/biom14091121.


MicroRNAs as Epigenetic Regulators of Obesity.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:595-627.

PMID: 39287866 DOI: 10.1007/978-3-031-63657-8_20.


References
1.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

2.
Anderson E, Gutierrez D, Hasty A . Adipose tissue recruitment of leukocytes. Curr Opin Lipidol. 2010; 21(3):172-7. PMC: 3381420. DOI: 10.1097/MOL.0b013e3283393867. View

3.
Lofgren P, Hoffstedt J, Naslund E, Wiren M, Arner P . Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction. Diabetologia. 2005; 48(11):2334-42. DOI: 10.1007/s00125-005-1961-6. View

4.
Balwierz P, Carninci P, Daub C, Kawai J, Hayashizaki Y, van Belle W . Methods for analyzing deep sequencing expression data: constructing the human and mouse promoterome with deepCAGE data. Genome Biol. 2009; 10(7):R79. PMC: 2728533. DOI: 10.1186/gb-2009-10-7-r79. View

5.
Zhu H, Shyh-Chang N, V Segre A, Shinoda G, Shah S, Einhorn W . The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011; 147(1):81-94. PMC: 3353524. DOI: 10.1016/j.cell.2011.08.033. View